Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicinova (MNOV) Profit After Tax (2021 - 2025)

Medicinova (MNOV) has disclosed Profit After Tax for 8 consecutive years, with -$3.8 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax changed N/A to -$3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$13.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$12.0 million for FY2025, 8.58% down from the prior year.
  • Profit After Tax for Q4 2025 was -$3.8 million at Medicinova, down from -$3.1 million in the prior quarter.
  • The five-year high for Profit After Tax was -$187799.0 in Q1 2021, with the low at -$4.3 million in Q2 2021.
  • Average Profit After Tax over 5 years is -$2.8 million, with a median of -$2.9 million recorded in 2023.
  • The sharpest move saw Profit After Tax plummeted 1703.21% in 2022, then surged 80.2% in 2023.
  • Over 5 years, Profit After Tax stood at -$2.1 million in 2021, then plummeted by 75.32% to -$3.7 million in 2022, then surged by 43.62% to -$2.1 million in 2023, then tumbled by 38.52% to -$2.9 million in 2024, then crashed by 31.94% to -$3.8 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$3.8 million, -$3.1 million, and -$3.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.